Novo Nordisk to invest up to $3.7 billion on diabetes pills to replace traditional insulin injections

photo_novo-nordisk

The Danish company said it planned to spend the money through to 2020 on six diabetes pills it has under development and that the sum included potential production facilities.

Read more

Posted in Glucose & Insulin